Graham Capital Management L.P. Purchases Shares of 33,661 Doximity, Inc. (NASDAQ:DOCS)

Graham Capital Management L.P. bought a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 33,661 shares of the company's stock, valued at approximately $1,797,000.

Other hedge funds have also bought and sold shares of the company. Global Retirement Partners LLC boosted its stake in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. raised its position in shares of Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after buying an additional 235 shares in the last quarter. Larson Financial Group LLC grew its position in Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares in the last quarter. Optimum Investment Advisors bought a new stake in shares of Doximity during the 4th quarter valued at $43,000. Finally, Kapitalo Investimentos Ltda bought a new stake in Doximity during the fourth quarter worth about $50,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Needham & Company LLC upped their target price on Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Wells Fargo & Company restated an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. Canaccord Genuity Group lifted their price target on Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research note on Friday, February 7th. Mizuho boosted their target price on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Finally, Truist Financial decreased their price objective on Doximity from $65.00 to $58.00 and set a "hold" rating for the company in a report on Thursday, April 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $65.39.

Insider Buying and Selling at Doximity

In related news, CFO Anna Bryson sold 45,000 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the sale, the chief financial officer now directly owns 357,165 shares in the company, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now owns 16,618 shares of the company's stock, valued at $946,062.74. This represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by corporate insiders.

Doximity Stock Performance

DOCS traded down $0.96 during mid-day trading on Thursday, reaching $58.54. 6,279,088 shares of the stock were exchanged, compared to its average volume of 2,054,390. Doximity, Inc. has a 1 year low of $23.27 and a 1 year high of $85.21. The company has a 50 day moving average price of $57.62 and a two-hundred day moving average price of $57.53. The stock has a market capitalization of $10.93 billion, a PE ratio of 58.54, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.